ACC 2022: Triple Therapy - When to Use and How Long

ACC 2022 Conference Coverage

D. Kumbhani

Management of AF patients with ACS

Lankenau

P. Kowey, D. Ice

Time to Retire Aspirin?

Top Ten Topics in Clinical Cardiology 2021

R. Mehran

Five Things Every Internist Should Know About Anticoagulants

McMaster University Department of Medicine

S. Mithoowani

Aspirin for the Primary Prevention of Cardiovascular Disease: What C…

Houston Methodist DeBakey Heart and Vascular Center

M. Miedema

ACP 2024 Insights: Acute Coronary Syndromes - Evaluation, Diagnosis …

Insights from 2024 ACP Annual Meeting

D. Berg

Treating Stenosis or Ischemia Does Not Improve Outcomes: Medical The…

Cedars Sinai

W. Boden

How to Manage Anticoagulation in Patients With Inherited Bleeding Di…

Bethany Samuelson Bannow

Perioperative Management of Antithrombotic Therapy

CHEST 2022 Coverage

J. Douketis

Ticagrelor with or without Aspirin in ACS after PCI (TICO)

American College of Cardiology

P. Block, Y. Jang

Therapy Post PCI: What Is the Rationale for DAPT and OAC? When to Us…

Complex Coronary Cases

U. Baber

Aspirin & Primary Prevention: What Do the Guidelines Say?

Houston Methodist DeBakey Heart and Vascular Center

M. Gulati

Peri-Operative Management of Anticoagulation

Icahn School of Medicine at Mount Sinai

A. Dunn

ESC 2023 Insights: STOPDAPT-3 - Study to Evaluate Safety of No Dual …

ESC 2023 Insights

M. Natsuaki

Aspirin for Primary Prevention

Salim Virani

MASTER DAPT: Dual Antiplatelet Therapy After PCI in Patients at High…

American College of Cardiology

V. Fuster, D. Itchhaporia, M. Mack, C. Albert, J. Grapsa

Highlights and Critiques of ACC/AHA/SCAI Revascularization Guidelines

ARCH Advanced Revascularization Symposium

D. A. Cox

Anticoagulation in ECLS - To Bleed, or Not to Clot...

UCLA Health

A. Young

Stable CAD: ASA Alone, Prolonged DAPT or Low-Dose Rivaroxaban?

Canadian Collaborative Research Network

M. Sabatine

Stress Testing in the Real World

Northwestern Medicine Cardiovascular Care

M. Eimer